Akt (Ab 473) Antibody

Product Specifications

Background

General protein kinase capable of phosphorylating several known proteins. Phosphorylates TBC1D4. Signals downstream of phosphatidylinositol 3-kinase (PI3K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I) . Plays a role in glucose transport by mediating insulin-induced translocation of the GLUT4 glucose transporter to the cell surface. Mediates the antiapoptotic effects of IGF-I. Mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. Promotes glycogen synthesis by mediating the insulin-induced activation of glycogen synthase.

NCBI Gene ID

207

Swiss Prot

P31749

Accession Number

NP_001014431.1

Host

Rabbit

Reactivity

Human, Mouse, Rat

Immunogen

Akt (Ab-473) antibody was raised against a peptide sequence around aa. 471~475 (Q-F-S-Y-S) derived from Human Akt.

Clonality

Polyclonal

Conjugation

Unconjugated

Type

Primary Antibodies

Field of Research

Other

Purification

Antibodies were purified by affinity-chromatography using epitope-specific peptide.

Concentration

1 mg/mL

Buffer

Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Store antibody at -20˚ C for up to one year.

Calculated Molecular Weight

60 kDa

Specificity

This antibody detects endogenous level of total Akt protein.

Applications Notes

Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100

Symbol

AKT1

NCBI Official Name

V-akt murine thymoma viral oncogene homolog 1

NCBI Organism

Homo sapiens

Background Reference 01

Baudhuin LM, et al. (2004) FASEB J Feb; 18 (2) : 341-3. Min YH, et al. (2004) Cancer Res; 64 (15) : 5225-31. Feng J, et al. (2004) J Biol Chem; 279 (34) : 35510-7. Ayala G, et al. (2004) Clin Cancer Res; 10 (19) : 6572-8. Lungu AO, et al. (2004) J Biol Chem; 279 (47) : 48794-800.